PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
AMPH vs. HWKN
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between AMPH and HWKN is 0.28, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.3

Performance

AMPH vs. HWKN - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Amphastar Pharmaceuticals, Inc. (AMPH) and Hawkins, Inc. (HWKN). The values are adjusted to include any dividend payments, if applicable.

-10.00%0.00%10.00%20.00%30.00%40.00%AugustSeptemberOctoberNovemberDecember2025
-8.07%
5.41%
AMPH
HWKN

Key characteristics

Sharpe Ratio

AMPH:

-0.85

HWKN:

1.68

Sortino Ratio

AMPH:

-1.10

HWKN:

2.40

Omega Ratio

AMPH:

0.85

HWKN:

1.31

Calmar Ratio

AMPH:

-0.72

HWKN:

3.26

Martin Ratio

AMPH:

-1.48

HWKN:

11.11

Ulcer Index

AMPH:

22.44%

HWKN:

6.12%

Daily Std Dev

AMPH:

38.90%

HWKN:

40.53%

Max Drawdown

AMPH:

-49.92%

HWKN:

-44.76%

Current Drawdown

AMPH:

-44.25%

HWKN:

-19.66%

Fundamentals

Market Cap

AMPH:

$1.74B

HWKN:

$2.34B

EPS

AMPH:

$3.01

HWKN:

$3.86

PE Ratio

AMPH:

12.04

HWKN:

28.64

PEG Ratio

AMPH:

2.77

HWKN:

3.75

Total Revenue (TTM)

AMPH:

$543.05M

HWKN:

$725.93M

Gross Profit (TTM)

AMPH:

$281.28M

HWKN:

$170.39M

EBITDA (TTM)

AMPH:

$200.15M

HWKN:

$121.70M

Returns By Period

In the year-to-date period, AMPH achieves a -2.40% return, which is significantly higher than HWKN's -9.87% return. Over the past 10 years, AMPH has underperformed HWKN with an annualized return of 11.79%, while HWKN has yielded a comparatively higher 20.75% annualized return.


AMPH

YTD

-2.40%

1M

-11.26%

6M

-8.07%

1Y

-34.70%

5Y*

12.59%

10Y*

11.79%

HWKN

YTD

-9.87%

1M

-14.88%

6M

5.41%

1Y

71.56%

5Y*

40.51%

10Y*

20.75%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

AMPH vs. HWKN — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

AMPH
The Risk-Adjusted Performance Rank of AMPH is 99
Overall Rank
The Sharpe Ratio Rank of AMPH is 88
Sharpe Ratio Rank
The Sortino Ratio Rank of AMPH is 1010
Sortino Ratio Rank
The Omega Ratio Rank of AMPH is 1010
Omega Ratio Rank
The Calmar Ratio Rank of AMPH is 88
Calmar Ratio Rank
The Martin Ratio Rank of AMPH is 77
Martin Ratio Rank

HWKN
The Risk-Adjusted Performance Rank of HWKN is 9191
Overall Rank
The Sharpe Ratio Rank of HWKN is 9191
Sharpe Ratio Rank
The Sortino Ratio Rank of HWKN is 8787
Sortino Ratio Rank
The Omega Ratio Rank of HWKN is 8686
Omega Ratio Rank
The Calmar Ratio Rank of HWKN is 9696
Calmar Ratio Rank
The Martin Ratio Rank of HWKN is 9393
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

AMPH vs. HWKN - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Amphastar Pharmaceuticals, Inc. (AMPH) and Hawkins, Inc. (HWKN). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for AMPH, currently valued at -0.85, compared to the broader market-2.000.002.00-0.851.68
The chart of Sortino ratio for AMPH, currently valued at -1.10, compared to the broader market-4.00-2.000.002.004.00-1.102.40
The chart of Omega ratio for AMPH, currently valued at 0.85, compared to the broader market0.501.001.502.000.851.31
The chart of Calmar ratio for AMPH, currently valued at -0.72, compared to the broader market0.002.004.006.00-0.723.26
The chart of Martin ratio for AMPH, currently valued at -1.48, compared to the broader market-30.00-20.00-10.000.0010.0020.00-1.4811.11
AMPH
HWKN

The current AMPH Sharpe Ratio is -0.85, which is lower than the HWKN Sharpe Ratio of 1.68. The chart below compares the historical Sharpe Ratios of AMPH and HWKN, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.004.00AugustSeptemberOctoberNovemberDecember2025
-0.85
1.68
AMPH
HWKN

Dividends

AMPH vs. HWKN - Dividend Comparison

AMPH has not paid dividends to shareholders, while HWKN's dividend yield for the trailing twelve months is around 0.62%.


TTM20242023202220212020201920182017201620152014
AMPH
Amphastar Pharmaceuticals, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
HWKN
Hawkins, Inc.
0.62%0.55%0.88%1.45%1.28%1.78%2.01%2.17%2.44%1.52%2.18%1.71%

Drawdowns

AMPH vs. HWKN - Drawdown Comparison

The maximum AMPH drawdown since its inception was -49.92%, which is greater than HWKN's maximum drawdown of -44.76%. Use the drawdown chart below to compare losses from any high point for AMPH and HWKN. For additional features, visit the drawdowns tool.


-50.00%-40.00%-30.00%-20.00%-10.00%0.00%AugustSeptemberOctoberNovemberDecember2025
-44.25%
-19.66%
AMPH
HWKN

Volatility

AMPH vs. HWKN - Volatility Comparison

The current volatility for Amphastar Pharmaceuticals, Inc. (AMPH) is 11.49%, while Hawkins, Inc. (HWKN) has a volatility of 13.12%. This indicates that AMPH experiences smaller price fluctuations and is considered to be less risky than HWKN based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


8.00%10.00%12.00%14.00%16.00%18.00%20.00%AugustSeptemberOctoberNovemberDecember2025
11.49%
13.12%
AMPH
HWKN

Financials

AMPH vs. HWKN - Financials Comparison

This section allows you to compare key financial metrics between Amphastar Pharmaceuticals, Inc. and Hawkins, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab